← Leaderboards
Emma Covey Johnson
Washington University
$1,259,496
Attributed
$1,259,496
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.8K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,259,496 · 3
By mechanism
K01$815,532 · 1
R03$311,000 · 1
F32$132,964 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Laura Jean Bierut$29,352,289
- Lilianna Solnica-Krezel$20,466,821
- Arpana Agrawal$26,588,609
- Li-Shiun Chen$7,324,917
- Megan Anne Cooper$7,117,802
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesEtiologySamplingVariantPleiotropismPathway InteractionsGeneticPublic HealthSourceGenetic VariantHeritabilityAddictionComorbidityGenome Wide Association StudyBiologicalGenome-WideGenetic Predisposition To DiseaseCostGenetic ArchitectureFutureCausal VariantGeneral PopulationCareer DevelopmentChronic
Grant awards (9)
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data$186,408
K01 · FY2025 · DA · contact PI
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data$157,281
K01 · FY2024 · DA · contact PI
Using genomics and extensive phenotyping to dissect the relationships between substance use disorders and chronic pain$155,500
R03 · FY2024 · DA · contact PI
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data$157,281
K01 · FY2023 · DA · contact PI
Using genomics and extensive phenotyping to dissect the relationships between substance use disorders and chronic pain$155,500
R03 · FY2023 · DA · contact PI
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data$157,281
K01 · FY2022 · DA · contact PI
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data$157,281
K01 · FY2021 · DA · contact PI
Identifying Contributions to the Genetic Correlation Between Alcohol Use Disorders and Schizophrenia$69,810
F32 · FY2020 · AA · contact PI
Identifying Contributions to the Genetic Correlation Between Alcohol Use Disorders and Schizophrenia$63,154
F32 · FY2018 · AA · contact PI